Dirk G. Brockstedt Rapt Therapeutics, Inc. (RAPT) insider trading activity

RAPT Quotes by TradingView

Dirk G. Brockstedt is CHIEF SCIENTIFIC OFFICER of RAPT Therapeutics, Inc.. Currently has a direct ownership of 27,820 shares of RAPT, which is worth approximately $31,158. The most recent transaction as insider was on Jan 05, 2024, when has been sold 898 shares (Common Stock) at a price of $22.78 per share, resulting in proceeds of $20,456. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.8K
0% 3M change
45.88% 12M change
Total Value Held $31,158

Dirk G. Brockstedt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 05 2024
SELL
Open market or private sale
$20,456 $22.78 p/Share
898 Reduced 3.13%
27,820 Common Stock
Dec 29 2023
BUY
Exercise of conversion of derivative security
$49,440 $6.18 p/Share
8,000 Added 22.81%
27,070 Common Stock
Jan 05 2023
SELL
Open market or private sale
$16,301 $21.97 p/Share
742 Reduced 3.75%
19,070 Common Stock
May 04 2022
SELL
Open market or private sale
$10,836 $15.05 p/Share
720 Reduced 3.51%
19,812 Common Stock
Apr 11 2022
SELL
Open market or private sale
$61,013 $23.05 p/Share
2,647 Reduced 11.79%
19,812 Common Stock
Apr 11 2022
BUY
Exercise of conversion of derivative security
$16,358 $6.18 p/Share
2,647 Added 10.54%
22,459 Common Stock
Mar 11 2022
SELL
Open market or private sale
$63,314 $23.91 p/Share
2,648 Reduced 11.79%
19,812 Common Stock
Mar 11 2022
BUY
Exercise of conversion of derivative security
$16,365 $6.18 p/Share
2,648 Added 10.55%
22,460 Common Stock
Feb 11 2022
SELL
Open market or private sale
$59,478 $22.47 p/Share
2,647 Reduced 11.79%
19,812 Common Stock
Feb 11 2022
BUY
Exercise of conversion of derivative security
$16,358 $6.18 p/Share
2,647 Added 10.54%
22,459 Common Stock
Jan 11 2022
SELL
Open market or private sale
$85,160 $32.16 p/Share
2,648 Reduced 11.79%
19,812 Common Stock
Jan 11 2022
BUY
Exercise of conversion of derivative security
$16,365 $6.18 p/Share
2,648 Added 10.55%
22,460 Common Stock
Jan 03 2022
SELL
Payment of exercise price or tax liability
$30,119 $36.73 p/Share
820 Reduced 4.14%
18,992 Common Stock
Dec 10 2021
SELL
Open market or private sale
$81,739 $30.88 p/Share
2,647 Reduced 11.79%
19,812 Common Stock
Dec 10 2021
BUY
Exercise of conversion of derivative security
$16,676 $6.3 p/Share
2,647 Added 10.54%
22,459 Common Stock
Nov 11 2021
SELL
Open market or private sale
$94,507 $35.69 p/Share
2,648 Reduced 11.79%
19,812 Common Stock
Nov 11 2021
BUY
Exercise of conversion of derivative security
$16,682 $6.3 p/Share
2,648 Added 10.55%
22,460 Common Stock
Oct 11 2021
SELL
Open market or private sale
$81,475 $30.78 p/Share
2,647 Reduced 11.79%
19,812 Common Stock
Oct 11 2021
BUY
Exercise of conversion of derivative security
$16,358 $6.18 p/Share
2,647 Added 10.54%
22,459 Common Stock
Sep 10 2021
SELL
Open market or private sale
$94,745 $35.78 p/Share
2,648 Reduced 11.79%
19,812 Common Stock
Sep 10 2021
BUY
Exercise of conversion of derivative security
$16,365 $6.18 p/Share
2,648 Added 10.55%
22,460 Common Stock
Aug 11 2021
SELL
Open market or private sale
$82,560 $31.19 p/Share
2,647 Reduced 11.79%
19,812 Common Stock
Aug 11 2021
BUY
Exercise of conversion of derivative security
$16,358 $6.18 p/Share
2,647 Added 10.54%
22,459 Common Stock
Jul 12 2021
SELL
Open market or private sale
$88,787 $33.53 p/Share
2,648 Reduced 11.79%
19,812 Common Stock
Jul 12 2021
BUY
Exercise of conversion of derivative security
$16,365 $6.18 p/Share
2,648 Added 10.55%
22,460 Common Stock
DGB

Dirk G. Brockstedt

CHIEF SCIENTIFIC OFFICER
South San Francisco, CA

Track Institutional and Insider Activities on RAPT

Follow RAPT Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RAPT shares.

Notify only if

Insider Trading

Get notified when an Rapt Therapeutics, Inc. insider buys or sells RAPT shares.

Notify only if

News

Receive news related to RAPT Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RAPT